Progression of diagnosis and treatment in acute pulmonary thromboembolism

doi:10.3969/j.issn.1004-583X.2016.04.001

Abstract

Abstract: In recent years, as the new evidence-based medical evidence on diagnosis and treatment of pulmonary thromboembolism(PTE) appear constantly, some new concepts have been pointed out, such as the clinical classification of the severity of acute PTE becomes more elaborated, recommendation for management of high-risk patients, plasma D-dimer is more suitable to rule out acute PTE, treatment of moderate-risk patients, early discharge or home treatment of low-risk patient and so on. In order to make clinicians get the newest trends in diagnosis and treatment of PTE and finally formulate the most effective therapeutic plan for patients with PTE, we unscramble the new guidelines on the diagnosis and management of acute PTE according to above mentioned problems.

Key words: pulmonary thromboembolism, thromboembolism, diagnosis, treatment, D-dimer

CLC Number:

R563.5

Yang Yuanhua, Zhou Rongrong. Progression of diagnosis and treatment in acute pulmonary thromboembolism[J]. Clinical Focus, 2016, 31(4): 349-351.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2016.04.001

https://huicui.hebmu.edu.cn/EN/Y2016/V31/I4/349

References

[1] Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism[J]. Eur Heart J, 2014,35(43): 3033-69, 3069a-3069k.
[2] Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism[J]. N Engl J Med,2006,354(22): 2317-2327.
[3] 杨媛华. 对基础医院肺血栓栓塞症处理策略的思考[J].中华医学杂志, 2015,95(30): 2419-2420.
[4] Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)[J]. Eur Heart J,2008,29(18): 2276-2315.
[5] Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism[J]. Am J Respir Crit Care Med, 2005, 172(8): 1041-1046.
[6] Fancher TL, White RH, Kravitz RL. Combined use of rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review[J]. BMJ,2004,329(7470): 821.
[7] Righini M, van Es J, Den EPL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study[J].JAMA, 2014,311(11): 1117-1124.
[8] Meyer G, Vicaut E, Danays T, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism[J]. N Engl J Med,2014,370(15): 1402-1411.
[9] Chatterjee S, Chakraborty A, Weinberg I, et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis[J]. JAMA,2014,311(23): 2414-2421.
[10] Kline JA, Steuerwald MT, Marchick MR, et al. Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure[J]. Chest, 2009, 136(5): 1202-1210.
[11] Wang C, Zhai Z, Yang Y, et al. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial[J]. Chest, 2010, 137(2): 254-262.
[12] Zhang Z, Zhai ZG, Liang LR, et al. Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis[J]. Thromb Res,2014,133(3): 357-363.
[13] Bagla S, Smirniotopoulos JB, van Breda A, et al. Ultrasound-accelerated catheter-directed thrombolysis for acute submassive pulmonary embolism[J]. J Vasc Interv Radiol, 2015,26(7): 1001-1006.
[14] 常生杰, 孙炳华, 卢乐平, 等. 选择性肺动脉内溶栓治疗肺栓塞20例临床体会[J]. 临床荟萃,2013,28(1): 69-70.
[15] Buller HR, Prins MH, Lensin AW, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism[J].N Engl J Med, 2012, 366(14): 1287-1297.
[16] Agnelli G, Buller HR, Cohen A, et al. Oral apixaban for the treatment of acute venous thromboembolism[J].N Engl J Med, 2013,369(9): 799-808.